+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Phenobarbitone to gabapentin: a guide to 82 years of anti-epileptic drug pharmacokinetic interactions



Phenobarbitone to gabapentin: a guide to 82 years of anti-epileptic drug pharmacokinetic interactions



Seizure 3(3): 163-170



With the introduction of three new anti-epileptic drugs (AEDs) in the UK during the past 4 years as adjunctive add-on therapy, the possibility of AED pharmacokinetic interactions has become a relevant consideration. This review highlights the current status of AED interactions with particular emphasis on those interactions that are likely to be frequently experienced or whose outcome is potentially clinically significant.

(PDF emailed within 0-6 h: $19.90)

Accession: 046973199

Download citation: RISBibTeXText

PMID: 8000709

DOI: 10.1016/S1059-1311(05)80184-0


Related references

Pharmacokinetic aspects of the anti-epileptic drug substance vigabatrin: focus on transporter interactions. Therapeutic Delivery 5(8): 927-942, 2015

Lack of a pharmacokinetic interaction between phenobarbitone and gabapentin. British Journal of Clinical Pharmacology 31(2): 171-174, 1991

Low-affinity block of the T-type alpha1G Ca2+ channel by the anti-epileptic drug gabapentin. Biophysical Journal 78(1 Part 2): 457A, 2000

Prediction of pharmacokinetic drug/drug interactions from In vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants. Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168, 2000

Anti-epileptic drug monitoring and interactions in epileptic therapy. British Journal of Pharmacology 131(Proceedings Supplement): 135P, October, 2000

Evaluation of pharmacokinetic drug-drug-interactions. Critical considerations of the relevance of pharmacokinetic drug-drug interactions of proton pump inhibitors in self medication. Medizinische Monatsschrift für Pharmazeuten 34(8): 270-278, 2011

Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine. British Journal of Clinical Pharmacology 69(5): 498-507, 2011

Levetiracetam: an anti-epileptic drug with interesting pharmacokinetic properties. Nederlands Tijdschrift Voor Geneeskunde 146(26): 1218-1221, 2002

Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs). Seizure 23(5): 371-376, 2014

Pharmacodynamic and pharmacokinetic interactions between alpha-methylparatyrosine and phenobarbitone. Pharmacology 49(5): 308-313, 1994

Clinically relevant anti-epileptic drug interactions. Journal of International Medical Research 18(1): 1-15, 1990

The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients. Proceedings of the Australian Association of Neurologists 13: 89-96, 1976

Pharmacokinetic drug-drug interactions between calcineurin inhibitors and proliferation signal inhibitors with anti-microbial agents: implications for therapeutic drug monitoring. Journal of Heart and Lung Transplantation 30(2): 124-135, 2011

The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies. Drug Metabolism and Disposition: the Biological Fate of Chemicals 30(1): 13-19, 2001

Pharmacokinetic drug interactions with anti-ulcer drugs. Clinical Pharmacokinetics 35(2): 135-150, 1998